Dishman Pharmaceuticals and Chemicals today reported a near two-fold jump in consolidated net profit to Rs 54.68 crore for the second quarter ended September 30, mainly on account of robust sales in contract research and manufacturing services segment.
The company had posted a net profit after taxes, minority interest and share of profit/(loss) of the associates of Rs 27.73 crore for the corresponding period year ago, Dishman Pharmaceuticals said in a BSE filing.
Consolidated total income from operations also rose to Rs 436.55 crore for the quarter under review as against Rs 380.39 crore in the same period last fiscal.
The stock was trading 5.23 per cent up at Rs 239.50 on BSE.
Disclaimer: No Business Standard Journalist was involved in creation of this content
